Deficiency of Intestinal α1-2-Fucosylation Exacerbates Ethanol-Induced Liver Disease in Mice.
Rongrong ZhouCristina LlorenteJinling CaoBei GaoYi DuanLu JiangYanhan WangVipin KumarPeter StärkelLars BodeXuegong FanBernd SchnablPublished in: Alcoholism, clinical and experimental research (2020)
Intestinal α1-2-fucosylation acts as a host-protective mechanism against EtOH-induced liver disease. 2'-FL is an oligosaccharide naturally present in human milk that could be considered as therapeutic agent for alcohol-associated liver disease.